Found 32 matching trials
A Clinical Trial of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Relapsed or Refractory Breast, Colorectal and Non-Small Cell Lung Cancer (0683-011)(TERMINATED) PHASE2 This is an investigational study to determine the response rate of relapsed...
Show More Location
Multiple Locations
Learn More & Join Trial
Clinical Trial of SAHA in Patients With Breast Cancer PHASE1 Purpose:
* evaluate the safety of Vorinostat.
* evaluate the effectiveness...
Show More Location
National University Hospital
Learn More & Join Trial
A Study of Carboplatin + Paclitaxel and MK0683 in Patients With Chemotherapy-naive Non-Small Cell Lung Cancer (NSCLC)(0683-066) PHASE1 The clinical study will evaluate safety, tolerability and Pharmacokinetics ...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Malignant Lymphoma (0683-030) PHASE1 The primary purpose of this trial is to determine the maximum tolerated dos...
Show More Location
Multiple Locations
Learn More & Join Trial
Phase I Study of MK-0683 in Combination With Bortezomib in Participants With Multiple Myeloma (MK-0683-098) PHASE1 The primary purpose of this clinical study is to determine the recommended ...
Show More Location
Multiple Locations
Learn More & Join Trial
Suberoylanilide Hydroxamic Acid (Vorinostat, MK-0683) Versus Placebo in Advanced Malignant Pleural Mesothelioma (MK-0683-014) PHASE3 The goal of this study is to assess the efficacy and safety of an oral inve...
Show More Location
Multiple Locations
Learn More & Join Trial
Suberoylanilide Hydroxamic Acid in Advanced Solid Tumors PHASE1 The purpose of this investigational study is to determine the safety and to...
Show More Location
Multiple Locations
Learn More & Join Trial
A Clinical Trial of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Advanced Multiple Myeloma (0683-004) PHASE1 The purposes of this study are:
* To determine the maximum tolerated dose ...
Show More Location
Multiple Locations
Learn More & Join Trial
Vorinostat in Combination With Vinorelbine in Patients With Advanced Cancer PHASE1 This is a multi-center, open-label non-randomized dose-escalation trial of ...
Show More Location
Centre RenΓ© GAUDUCHEAU
Learn More & Join Trial
A Clinical Trial of Vorinostat (MK0683, SAHA) in Combination With FDA Approved Cancer Drugs in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)(0683-056) PHASE2 This Phase III clinical trial which incorporates an initial Phase II compon...
Show More Location
Multiple Locations
Learn More & Join Trial